Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$419,818
+$46,332 QoQ
Shares Held
327,983
+30.8% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 259 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. GERN ranks #137 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,818 | 327,983 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $373,486 | 250,662 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $392,121 | 297,062 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $365,446 | 266,749 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $512,023 | 363,137 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $485,439 | 305,308 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,231,633 | 347,919 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,469,411 | 323,659 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,410,910 | 332,762 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $896,194 | 271,574 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $554,216 | 262,662 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $556,843 | 262,662 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $843,145 | 262,662 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $488,603 | 225,163 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $422,873 | 174,741 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $448,379 | 191,615 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $211,945 | 136,739 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $195,633 | 143,848 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $140,493 | 115,159 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $86,001 | 62,775 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $170,050 | 120,603 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $83,371 | 52,767 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $203,249 | 127,830 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $226,556 | 130,205 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $202,343 | 92,818 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $110,453 | 92,818 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||